The safety, tolerability and efficacy both in terms of prophylaxis and of the therapy of bleeding episodes achievable with Advate® enables us to issue an overall favorable ethical judgment. It is nonetheless advisable that decision makers work towards the creation of procedures of continuity in treatment and towards global care for patients, as well as towards guaranteeing equal access to medicine for all patients.

Di Pietro, M. L., HTA of Advate in the treatment andthe prophylaxis of Hemophilia A: ethicalconsiderations, <<ITALIAN JOURNAL OF PUBLIC HEALTH>>, 2012; 9 (4): 97-102 [http://hdl.handle.net/10807/40096]

HTA of Advate in the treatment and the prophylaxis of Hemophilia A: ethical considerations

Di Pietro, Maria Luisa
2012

Abstract

The safety, tolerability and efficacy both in terms of prophylaxis and of the therapy of bleeding episodes achievable with Advate® enables us to issue an overall favorable ethical judgment. It is nonetheless advisable that decision makers work towards the creation of procedures of continuity in treatment and towards global care for patients, as well as towards guaranteeing equal access to medicine for all patients.
2012
Inglese
Di Pietro, M. L., HTA of Advate in the treatment andthe prophylaxis of Hemophilia A: ethicalconsiderations, <<ITALIAN JOURNAL OF PUBLIC HEALTH>>, 2012; 9 (4): 97-102 [http://hdl.handle.net/10807/40096]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/40096
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact